Icon PLC IJF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €180.75
- Day Range
- €176.05–181.15
- 52-Week Range
- €60.76–289.60
- Bid/Ask
- €176.90 / €177.90
- Shares Outstanding
- 74.92M
- Market Cap
- €13.25B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 28.46
- Price/Sales
- 1.95
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 2.54%
Company Profile
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon’s services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 41,900
- Website
- https://www.iconplc.com
Competitors
Valuation
Metric | IJF | IQV | FTRE |
|---|---|---|---|
Price/Earnings (Normalized) | 28.46 | 21.18 | 150.06 |
Price/Book Value | 1.68 | 6.71 | 3.64 |
Price/Sales | 1.95 | 2.65 | 0.71 |
Price/Cash Flow | 17.50 | 17.09 | 33.56 |
Price/Earnings
IJF
IQV
FTRE
Financial Strength
Metric | IJF | IQV | FTRE |
|---|---|---|---|
Quick Ratio | 1.27 | 0.74 | 0.88 |
Current Ratio | 1.32 | 0.83 | 0.97 |
Interest Coverage | 3.49 | 2.93 | 0.36 |
Quick Ratio
IJF
IQV
FTRE
Profitability
Metric | IJF | IQV | FTRE |
|---|---|---|---|
Return on Assets (Normalized) | 3.47% | 7.28% | 2.76% |
Return on Equity (Normalized) | 6.12% | 34.12% | 13.75% |
Return on Invested Capital (Normalized) | 5.69% | 12.43% | 8.10% |
Return on Assets
IJF
IQV
FTRE
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|QdZFB&@@ | LOCK|$cP | $259B | |||
| Danaher Corp DHR | LOCK|<hC%Xt^> | LOCK|Bq@ | $163B | |||
| IDEXX Laboratories Inc IDXX | LOCK|TFblK?$# | LOCK|RXQ | $55B | |||
| Agilent Technologies Inc A | LOCK|!&?LQPFl | LOCK|#%r | $49B | |||
| Waters Corp WAT | LOCK|PhcK>VQ | LOCK|wL | $45B | |||
| IQVIA Holdings Inc IQV | LOCK|gKZ@<>? | LOCK|^JJ^ | $45B | |||
| Mettler-Toledo International Inc MTD | LOCK|R%yBzz>d | LOCK|^YY@ | $34B | |||
| Illumina Inc ILMN | LOCK|^&y?MZ | LOCK|pgV! | $32B | |||
| Labcorp Holdings Inc LH | LOCK|$dZL^@# | LOCK|znX? | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|<<NtFR | LOCK|WMvgf | $29B |
United States